Prognostic factors and effectiveness of treatment in acute renal failure due to multiple myeloma: A review of 50 cases. Report of the Italien Renal Immunopathology Group

C. Pozzi, S. Pasquali, U. Donini, S. Casanova, G. Banfi, G. Tiraboschi, L. Furci, M. T. Porri, M. Ravelli, A. Lupo, F. P. Schena, C. Brunati, E. Imbasciati, F. Locatelli

Research output: Contribution to journalArticle

Abstract

We studied 50 patients with myeloma acute renal failure to investigate possible prognostic factors and to evaluate the effectiveness of the various treatment schedules used. Renal failure was reversible 1 month after the onset in 50% of the patients considered. The patients treated with chemotherapy and plasma exchange recovered renal function more frequently (61% of the cases) than those treated only with chemotherapy (27%). The most important clinical prognostic factors were total proteins, serum creatinine values and myeloma type. Considering the histological findings, the prognosis correlated with the severity of the lesions and number of tubular casts. Survival at 1 year was higher in the patients who regained renal function than in those in whom renal function did not improve.

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalClinical Nephrology
Volume28
Issue number1
Publication statusPublished - 1987

Fingerprint

Multiple Myeloma
Acute Kidney Injury
Kidney
Drug Therapy
Plasma Exchange
Renal Insufficiency
Blood Proteins
Creatinine
Appointments and Schedules
Survival

ASJC Scopus subject areas

  • Nephrology

Cite this

Prognostic factors and effectiveness of treatment in acute renal failure due to multiple myeloma : A review of 50 cases. Report of the Italien Renal Immunopathology Group. / Pozzi, C.; Pasquali, S.; Donini, U.; Casanova, S.; Banfi, G.; Tiraboschi, G.; Furci, L.; Porri, M. T.; Ravelli, M.; Lupo, A.; Schena, F. P.; Brunati, C.; Imbasciati, E.; Locatelli, F.

In: Clinical Nephrology, Vol. 28, No. 1, 1987, p. 1-9.

Research output: Contribution to journalArticle

Pozzi, C, Pasquali, S, Donini, U, Casanova, S, Banfi, G, Tiraboschi, G, Furci, L, Porri, MT, Ravelli, M, Lupo, A, Schena, FP, Brunati, C, Imbasciati, E & Locatelli, F 1987, 'Prognostic factors and effectiveness of treatment in acute renal failure due to multiple myeloma: A review of 50 cases. Report of the Italien Renal Immunopathology Group', Clinical Nephrology, vol. 28, no. 1, pp. 1-9.
Pozzi, C. ; Pasquali, S. ; Donini, U. ; Casanova, S. ; Banfi, G. ; Tiraboschi, G. ; Furci, L. ; Porri, M. T. ; Ravelli, M. ; Lupo, A. ; Schena, F. P. ; Brunati, C. ; Imbasciati, E. ; Locatelli, F. / Prognostic factors and effectiveness of treatment in acute renal failure due to multiple myeloma : A review of 50 cases. Report of the Italien Renal Immunopathology Group. In: Clinical Nephrology. 1987 ; Vol. 28, No. 1. pp. 1-9.
@article{e3b6591ddd0e48beb4ee5bd2ae55411a,
title = "Prognostic factors and effectiveness of treatment in acute renal failure due to multiple myeloma: A review of 50 cases. Report of the Italien Renal Immunopathology Group",
abstract = "We studied 50 patients with myeloma acute renal failure to investigate possible prognostic factors and to evaluate the effectiveness of the various treatment schedules used. Renal failure was reversible 1 month after the onset in 50{\%} of the patients considered. The patients treated with chemotherapy and plasma exchange recovered renal function more frequently (61{\%} of the cases) than those treated only with chemotherapy (27{\%}). The most important clinical prognostic factors were total proteins, serum creatinine values and myeloma type. Considering the histological findings, the prognosis correlated with the severity of the lesions and number of tubular casts. Survival at 1 year was higher in the patients who regained renal function than in those in whom renal function did not improve.",
author = "C. Pozzi and S. Pasquali and U. Donini and S. Casanova and G. Banfi and G. Tiraboschi and L. Furci and Porri, {M. T.} and M. Ravelli and A. Lupo and Schena, {F. P.} and C. Brunati and E. Imbasciati and F. Locatelli",
year = "1987",
language = "English",
volume = "28",
pages = "1--9",
journal = "Clinical Nephrology",
issn = "0301-0430",
publisher = "Dustri-Verlag Dr. Karl Feistle",
number = "1",

}

TY - JOUR

T1 - Prognostic factors and effectiveness of treatment in acute renal failure due to multiple myeloma

T2 - A review of 50 cases. Report of the Italien Renal Immunopathology Group

AU - Pozzi, C.

AU - Pasquali, S.

AU - Donini, U.

AU - Casanova, S.

AU - Banfi, G.

AU - Tiraboschi, G.

AU - Furci, L.

AU - Porri, M. T.

AU - Ravelli, M.

AU - Lupo, A.

AU - Schena, F. P.

AU - Brunati, C.

AU - Imbasciati, E.

AU - Locatelli, F.

PY - 1987

Y1 - 1987

N2 - We studied 50 patients with myeloma acute renal failure to investigate possible prognostic factors and to evaluate the effectiveness of the various treatment schedules used. Renal failure was reversible 1 month after the onset in 50% of the patients considered. The patients treated with chemotherapy and plasma exchange recovered renal function more frequently (61% of the cases) than those treated only with chemotherapy (27%). The most important clinical prognostic factors were total proteins, serum creatinine values and myeloma type. Considering the histological findings, the prognosis correlated with the severity of the lesions and number of tubular casts. Survival at 1 year was higher in the patients who regained renal function than in those in whom renal function did not improve.

AB - We studied 50 patients with myeloma acute renal failure to investigate possible prognostic factors and to evaluate the effectiveness of the various treatment schedules used. Renal failure was reversible 1 month after the onset in 50% of the patients considered. The patients treated with chemotherapy and plasma exchange recovered renal function more frequently (61% of the cases) than those treated only with chemotherapy (27%). The most important clinical prognostic factors were total proteins, serum creatinine values and myeloma type. Considering the histological findings, the prognosis correlated with the severity of the lesions and number of tubular casts. Survival at 1 year was higher in the patients who regained renal function than in those in whom renal function did not improve.

UR - http://www.scopus.com/inward/record.url?scp=0023628378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023628378&partnerID=8YFLogxK

M3 - Article

C2 - 3621685

AN - SCOPUS:0023628378

VL - 28

SP - 1

EP - 9

JO - Clinical Nephrology

JF - Clinical Nephrology

SN - 0301-0430

IS - 1

ER -